Trial record 1 of 1 for:    NCT01148498
Previous Study | Return to List | Next Study

A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: June 18, 2010
Last updated: September 18, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 18, 2012